|Bid||224.85 x 1200|
|Ask||226.05 x 1000|
|Day's Range||224.46 - 227.44|
|52 Week Range||197.47 - 306.08|
|Beta (5Y Monthly)||0.78|
|PE Ratio (TTM)||22.10|
|Earnings Date||Jan 28, 2021 - Feb 01, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||285.58|
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $225.55, marking a -0.25% move from the previous day.
The Zacks Analyst Blog Highlights: Intellia Therapeutics, Editas Medicine, Fate Therapeutic, CRISPR Therapeutics and Vertex Pharmaceuticals
Last year, companies working on coronavirus vaccines led gains in biotech stocks. Considering these elements, here are my top biotech stocks to buy in 2021. Moderna (NASDAQ: MRNA) shares climbed more than 430% last year.